All Releases
 |
MiddleBrook Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 4350
Jan 5, 2010
|
9.9 KB |
|
| |
WESTLAKE, Texas, Jan 05, 2010 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) announced today that on
Dec. 31, 2009, it granted options to purchase a total of 5,000 shares of
MiddleBrook's common stock to two (2) new employees as a material
inducement for them to join MiddleBrook. The options were granted...
|
|
MiddleBrook Pharmaceuticals Reduces Field Sales Force and Corporate Staff, Receives Notice from Nasdaq Regarding Minimum Bid Price Requirement
Dec 3, 2009
|
13.2 KB |
|
| |
WESTLAKE, Texas, Dec 03, 2009 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced a
reduction of its field sales force and corporate staff. Effective
December 4, 2009, MiddleBrook will reduce the number of its sales
managers and field sales representatives by about one-third, to
approx...
|
|
MiddleBrook Pharmaceuticals Reports Third Quarter 2009 Results
Nov 5, 2009
|
29.3 KB |
|
| |
WESTLAKE, Texas, Nov 05, 2009 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced its
financial and operational results for the quarter ended Sept. 30, 2009.
"MOXATAG tripled its share of the oral-solid penicillin-class antibiotic
market during the 2009 third quarter," said MiddleBrook President and ...
|
|
MiddleBrook Pharmaceuticals Schedules Third Quarter 2009 Results Conference Call and Webcast
Oct 15, 2009
|
11.1 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Oct. 15, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is scheduled to
announce its results for the 2009 third quarter on Thursday, Nov. 5,
2009, before...
|
|
MOXATAG® Supports Health Education on FamilyDoctor.org
Oct 12, 2009
|
12.9 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Oct. 12, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), the maker of the first
and only FDA-approved once-daily amoxicillin, MOXATAG (extended-release
amoxi...
|
|
MiddleBrook Pharmaceuticals Announces Sales Force Realignment, Cost-Saving Measures
Sep 1, 2009
|
14.4 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Sep. 1, 2009--
MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK) today announced a
strategic realignment of its field sales force to more aggressively
preserve the Company’...
|
|
MiddleBrook Pharmaceuticals Reports Second Quarter 2009 Results
Aug 6, 2009
|
36.8 KB |
|
| |
Highlights:
WESTLAKE, Texas--(BUSINESS WIRE)--Aug. 6, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced
financial and operational results for the quarter ended June ...
|
|
MiddleBrook Pharmaceuticals Announces $20 Maximum Copay Program for MOXATAG®
Jul 15, 2009
|
13.6 KB |
|
| |
WESTLAKE, Texas, Jul 15, 2009 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), announced today that it has implemented a $20 maximum copay program for MOXATAG (amoxicillin extended-release) Tablets, 775 mg. The program is designed to keep a patient's net out-of-pocket copay expense for a MOXATAG prescription at $20 or less. T...
|
|
MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Second Quarter 2009 Financial and Operational Results
Jul 14, 2009
|
10.2 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Jul. 14, 2009-- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is scheduled to announce its financial results for the 2009 second quarter on Thursday, August 6, 2009, before the market opens. At 9:00 a.m. (ET) on that day, MiddleBrook management will conduct a conference call to review results for the 2009 sec...
|
|
MiddleBrook Pharmaceuticals Secures $10 Million Revolving Line of Credit
Jul 1, 2009
|
16.1 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Jul. 1, 2009--
...
|
|
MiddleBrook Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 4350
Jun 3, 2009
|
9.9 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Jun. 3, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq:MBRK) today announced that on
May 29, 2009, it granted options to purchase a total of 3,600 shares of
Mid...
|
|
MiddleBrook Pharmaceuticals Reports First Quarter 2009 Results
May 7, 2009
|
36.1 KB |
|
| |
...
|
|
MiddleBrook Pharmaceuticals Launches MOXATAG™ Website, Announces Early Prescription Data for MOXATAG
May 1, 2009
|
18.2 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--May. 1, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) has launched a website
for MOXATAG (extended-release amoxicillin) Tablets, 775 mg. MOXATAG is
the first and only ...
|
|
MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for First Quarter 2009 Financial and Operational Results
Apr 6, 2009
|
10.9 KB |
|
| |
WESTLAKE, Texas, Apr 06, 2009 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK) is scheduled to
announce its financial results for the 2009 first quarter on Thursday,
May 7, 2009, before the market opens. At 9:00 a.m. (ET) on that day,
MiddleBrook management will conduct a conference call to review results ...
|
|
MiddleBrook Pharmaceuticals Launches MOXATAG™, the First and Only FDA-Approved Once-Daily Amoxicillin
Mar 16, 2009
|
13.9 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Mar. 16, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today launched MOXATAG
(extended-release amoxicillin) Tablets, 775 mg, the first and only
FDA-approve...
|
|
Company Profile for MiddleBrook Pharmaceuticals, Inc.
Mar 13, 2009
|
9.3 KB |
|
| |
Mar 13, 2009 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. We have developed a proprietary delivery technology called PULSYS®, which enables the pulsatile deli...
|
|
MiddleBrook Pharmaceuticals Reports 2008 Fourth Quarter and Full-Year Financial and Operational Results
Mar 5, 2009
|
38.9 KB |
|
| |
...
|
|
MiddleBrook Pharmaceuticals to Webcast Management Presentation at the Barclays Capital Global Healthcare Conference
Mar 2, 2009
|
10.9 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Mar. 2, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced that
MiddleBrook Executive Vice President and CFO David Becker will be
presentin...
|
|
MiddleBrook Pharmaceuticals' Nationwide Field Sales Force Hired
Feb 25, 2009
|
14.8 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Feb. 25, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced that it
has completed the hiring of its 271-person nationwide field sales force.
The 271 territo...
|
|
MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full-Year Financial Results
Feb 19, 2009
|
10.7 KB |
|
| |
WESTLAKE, Texas--(BUSINESS WIRE)--Feb. 19, 2009--
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is scheduled to
announce its financial results for the 2008 fourth quarter and full year
on Thursday, Mar...
|
|
|
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}
.jpg){kind=small}